What s New With Boston Scientific Stock? forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.
Digital Health Innovation Award: MedBridge
Best Hospital Technology Implementation: Hicuity Health
Best Health Network Technology Implementation: iMedX
Best Overall MedTech Software: NantHealth, Eviti Connect
Best Overall MedTech Company: Convey Health
Best Overall Digital Health Company: Doctor On Demand
Clinical and Health Administration
Best Compliance Solution: HOTB Software
Best Compliance Management Solution Provider: MedTrainer
Best Patient Registration & Scheduling Solution: Kyruus, ProviderMatch for Consumers
Best Computerized Decision Support Solution: Elsevier ClinicalPath
Best Overall Health Informatics Solution: Vim
Health Administration Innovation Award: Hospital IQ
Patient Engagement
Best Overall Patient Engagement Solution: Vocera Communications, Inc., Vocera Ease
Best Overall Patient Engagement Service: Greenphire Patient Convenience Suite: ClinCard & ConneX
MedTech Breakthrough Honors Standout Digital Health and Medical Technology Innovation in 2021 MedTech Breakthrough Awards Program
Share Article
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies In our 5th annual MedTech Breakthrough Awards program we are thrilled to recognize the digital health leaders that doubled down, pivoted and accelerated MedTech innovation in a time of need to build a new health system that better supports the entire care journey” LOS ANGELES (PRWEB) May 06, 2021
MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced the winners of the organization’s fifth annual awards program, showcasing technologies and companies that drive innovation and exemplify the best in digital health and medical technolo
Boston Scientific Announces Results For First Quarter 2021
News provided by
Share this article
Share this article
MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.752 billion during the first quarter of 2021. This represents growth of 8.2 percent on a reported basis, 5.6 percent on an operational
1 basis and 5.9 percent on an organic
2 basis, all compared to the prior year period. The company reported GAAP net income available to common stockholders of $327 million or $0.23 per share (EPS), compared to GAAP net income of $11 million or $0.01 per share a year ago, and achieved adjusted EPS of $0.37 for the period, compared to $0.28 a year ago.
Boston Scientific Announces Results For Fourth Quarter And Full Year 2020
News provided by
Share this article
Share this article
MARLBOROUGH, Mass., Feb. 3, 2021 /PRNewswire/ Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.708 billion during the fourth quarter of 2020. This represents a decline of (6.8) percent on a reported basis, (8.3) percent on an operational
1 basis and (8.0) percent on an organic
2 basis, all compared to the prior year period. Included within organic results is a negative 370 basis point impact associated with the conversion of U.S. WATCHMAN™ customers to a consignment inventory model and transition to the next-generation WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device. The company reported GAAP net income available to common stockholders of $138 million or $0.10 per share (EPS), compared to GAAP net income of $3.996 billion or $2.83 per share a year ago and achieved adjusted EPS of $0.23 for the period, compared to $0.